Aktuellt
SENASTE
The immediate impact is likely to be somewhat negative as the Q3 confirms the risk of a negative Delta impact. Our view is that this is a temporary effect as we point to the existence of efficient COVID vaccines. Any pressure on XVIVO's valuation at this stage is probably a good opportunity to invest in XVIVO's future growth drivers.
LÄS MER
